相似文献
1
Differential effects of aging on activin A and its binding protein, follistatin, across the menopause transition.
Fertil Steril. 2007 Oct;88(4):1003-5. doi: 10.1016/j.fertnstert.2006.12.009. Epub 2007 Apr 16.
2
Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
J Clin Endocrinol Metab. 1998 Sep;83(9):3302-7. doi: 10.1210/jcem.83.9.5130.
3
Inhibins, activins, and follistatin in the aging female and male.
Semin Reprod Med. 2004 Aug;22(3):209-17. doi: 10.1055/s-2004-831896.
4
Regulation of gonadotropins by inhibin and activin.
Semin Reprod Med. 2004 Aug;22(3):253-67. doi: 10.1055/s-2004-831901.
5
Activins in reproductive biology and beyond.
Hum Reprod Update. 2016 Apr;22(3):342-57. doi: 10.1093/humupd/dmv058. Epub 2016 Feb 15.
6
Inhibins, activins and follistatin: actions on the testis.
Mol Cell Endocrinol. 2001 Jun 30;180(1-2):87-92. doi: 10.1016/s0303-7207(01)00502-0.
7
Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.
Mol Cell Endocrinol. 2012 Aug 15;359(1-2):43-52. doi: 10.1016/j.mce.2012.01.025. Epub 2012 Feb 4.
8
Inhibins, activins and follistatin in reproduction.
Hum Reprod Update. 2002 Nov-Dec;8(6):529-41. doi: 10.1093/humupd/8.6.529.
9
Novel ovarian regulatory peptides: inhibin, activin, and follistatin.
Clin Obstet Gynecol. 1990 Sep;33(3):690-702. doi: 10.1097/00003081-199009000-00031.
10
An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis.
Biol Reprod. 1993 Jan;48(1):15-23. doi: 10.1095/biolreprod48.1.15.
引用本文的文献
1
Association between follicle-stimulating hormone and nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus.
J Diabetes. 2023 Aug;15(8):640-648. doi: 10.1111/1753-0407.13394. Epub 2023 May 23.
2
Ovarian Aging: Role of Pituitary-Ovarian Axis Hormones and ncRNAs in Regulating Ovarian Mitochondrial Activity.
Front Endocrinol (Lausanne). 2021 Dec 16;12:791071. doi: 10.3389/fendo.2021.791071. eCollection 2021.
3
The Ovarian Transcriptome of Reproductively Aged Multiparous Mice: Candidate Genes for Ovarian Cancer Protection.
Biomolecules. 2020 Jan 9;10(1):113. doi: 10.3390/biom10010113.
4
Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.
Mol Cell Endocrinol. 2020 Jan 15;500:110632. doi: 10.1016/j.mce.2019.110632. Epub 2019 Nov 2.
5
Gonadotropins and Their Association with the Risk of Prediabetes and Type 2 Diabetes in Middle-Aged Postmenopausal Women.
Dis Markers. 2019 Aug 5;2019:2384069. doi: 10.1155/2019/2384069. eCollection 2019.
6
Different anti-Műllerian hormone (AMH) levels respond to distinct ovarian stimulation methods in assisted reproductive technology (ART): Clues to better ART outcomes.
Reprod Med Biol. 2019 Apr 4;18(3):263-272. doi: 10.1002/rmb2.12270. eCollection 2019 Jul.
7
The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer.
Endocrinology. 2019 May 1;160(5):1097-1110. doi: 10.1210/en.2019-00015.
8
Hormone Replacement Therapy: Would it be Possible to Replicate a Functional Ovary?
Int J Mol Sci. 2018 Oct 14;19(10):3160. doi: 10.3390/ijms19103160.
9
Decreased bone mineral density in rats rendered follicle-deplete by an ovotoxic chemical correlates with changes in follicle-stimulating hormone and inhibin A.
Calcif Tissue Int. 2012 Mar;90(3):239-49. doi: 10.1007/s00223-011-9565-2. Epub 2012 Jan 17.
10
Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin.
Mol Cell Endocrinol. 2009 Oct 30;310(1-2):11-20. doi: 10.1016/j.mce.2009.07.001. Epub 2009 Jul 15.
本文引用的文献
1
Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status.
J Clin Endocrinol Metab. 2003 Apr;88(4):1516-22. doi: 10.1210/jc.2002-020777.
2
Neuroendocrine vs. paracrine control of follicle-stimulating hormone.
Arch Med Res. 2001 Nov-Dec;32(6):533-43. doi: 10.1016/s0188-4409(01)00318-6.
3
Actions of activins, inhibins and follistatins: implications in anterior pituitary function.
Clin Exp Pharmacol Physiol. 2001 Mar;28(3):244-8. doi: 10.1046/j.1440-1681.2001.03422.x.
4
Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women.
Fertil Steril. 1999 Apr;71(4):658-62. doi: 10.1016/s0015-0282(98)00529-9.
5
Inhibin and reproductive aging in women.
Maturitas. 1998 Oct 12;30(2):193-204. doi: 10.1016/s0378-5122(98)00074-7.
6
Influence of age and sex on serum concentrations of total dimeric activin A.
Eur J Endocrinol. 1998 Nov;139(5):487-92. doi: 10.1530/eje.0.1390487.
7
Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activin A may contribute in part to the rise in follicular phase follicle-stimulating hormone of aging cycling women.
J Clin Endocrinol Metab. 1998 Sep;83(9):3302-7. doi: 10.1210/jcem.83.9.5130.
8
Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin.
J Endocrinol. 1998 Feb;156(2):275-82. doi: 10.1677/joe.0.1560275.
9
Inhibin interferes with activin signaling at the level of the activin receptor complex in Chinese hamster ovary cells.
Endocrinology. 1997 Jul;138(7):2928-36. doi: 10.1210/endo.138.7.5250.
10
Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Mol Cell Biol. 1997 Mar;17(3):1682-91. doi: 10.1128/MCB.17.3.1682.
Zotero 插件